Senseonics Holdings SENS
NASDAQ SENS
$8.72 -0.61 (-6.55%)
As of: Sep 9, 2026 · 3:59 PM EDT

Senseonics Holdings (SENS) Cash & Equivalents (2014 - 2026)

Senseonics Holdings' (SENS) quarterly Cash & Equivalents came in at $142.7 million in Q2 2026, up 12.9% year-over-year from $126.4 million in Q2 2025, and up 121.93% quarter-over-quarter from $64.3 million in Q1 2026.

Analysis

Senseonics Holdings (SENS) Cash & Equivalents (2014 - 2026) Analysis & Trends

Senseonics Holdings (SENS) has reported Cash & Equivalents for 13 consecutive years, with $142.7 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash & Equivalents rose 12.9% year-over-year to $142.7 million in Q2 2026; TTM through Jun 2026 was $142.7 million, a 12.9% increase from a year earlier, with the FY2025 full-year figure at $40.2 million, down 46.06% from the prior year.
  • Cash & Equivalents was $142.7 million for Q2 2026 at Senseonics Holdings, up from $64.3 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $166.9 million in Q1 2022 and troughed at $35.8 million in Q4 2022.
  • A 5-year average of $103.3 million and a median of $104.8 million in 2024 frame the typical range for Cash & Equivalents.
  • Across the five-year window, Cash & Equivalents soared 111.52% in 2023 and sank 46.06% in 2025, its largest moves.
  • Over 5 years, Cash & Equivalents stood at $35.8 million in 2022, then jumped by 111.52% to $75.7 million in 2023, then retreated by 1.47% to $74.6 million in 2024, then slumped by 46.06% to $40.2 million in 2025, then soared by 254.68% to $142.7 million in 2026.
  • The last three Cash & Equivalents figures came in at $142.7 million (Q2 2026), $64.3 million (Q1 2026), and $40.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 5.10 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 2.76 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 1.69 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 3.39 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 539.00 Mn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 2.91 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 1.36 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 1.11 Bn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 482.30 Mn
10 Senseonics Holdings 507.86 Mn 267.25 Mn 8.56 Mn 142.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 142.70 Mn
Mar 31, 2026 64.30 Mn
Dec 31, 2025 40.23 Mn
Sep 30, 2025 111.00 Mn
Jun 30, 2025 126.40 Mn
Mar 31, 2025 64.20 Mn
Dec 31, 2024 74.60 Mn
Sep 30, 2024 74.50 Mn
Jun 30, 2024 84.60 Mn
Mar 31, 2024 98.70 Mn
Dec 31, 2023 75.71 Mn
Sep 30, 2023 125.40 Mn
Jun 30, 2023 125.10 Mn
Mar 31, 2023 136.60 Mn
Dec 31, 2022 35.79 Mn
Sep 30, 2022 163.00 Mn
Jun 30, 2022 150.50 Mn
Mar 31, 2022 166.90 Mn
Dec 31, 2021 33.46 Mn
Sep 30, 2021 201.10 Mn